Telangiectasia Macularis Multiplex Acquisita and its Potential Association with Calcium Channel Blockers: A Retrospective Study of 46 Chinese Patients
DOI:
https://doi.org/10.2340/actadv.v104.40447Keywords:
telangiectasia macularis multiplex acquisita, telangiectasis, calcium channel blockersAbstract
Telangiectasia macularis multiplex acquisita is an acquired cutaneous telangiectasis of unknown aetiology, and it lacks both effective and cost-efficient treatment. This study aims to identify a novel potential associated factor of the disease and explore feasible therapeutic interventions. In this retrospective case series study, 46 Chinese patients diagnosed with telangiectasia macularis multiplex acquisita between 1 January 2007 and 18 May 2023 were included. The median age of onset was 43 years (23 to 60 years), and the male to female ratio was 10.5:1. Besides previously reported associations including chronic liver disorders, alcohol consumption, and smoking, a potential association was found between use of calcium channel blockers and development of telangiectasia macularis multiplex acquisita. Twenty-two of 27 hypertensive patients took calcium channel blockers, with 17 followed up. Ten out of 17 displayed a range of improvements following the cessation of calcium channel blockers; 1 patient reported no lesion change post-discontinuation of calcium channel blockers; 1 patient continued their medication but showed partial improvement after 2 pulsed dye laser treatments; 1 patient observed lesion colour lightening without altering hypertensive medication or other specific treatments; and another 4 kept their previous hypertensive regimen due to blood pressure stability concerns, with no change in their lesions. The study proposes that cessation of calcium channel blockers can be a novel therapeutic approach for affected individuals.
Downloads
References
Chang CH, Lu PH, Kuo CJ, Yang CH. Telangiectasia macularis multiplex acquisita: a new entity in Chinese populations and an analysis of associated factors. Int J Dermatol 2013; 52: 426-431.
https://doi.org/10.1111/j.1365-4632.2011.05331.x DOI: https://doi.org/10.1111/j.1365-4632.2011.05331.x
Zhang ZW, Wu H, Tang KF, Fan YM. Clinicodermoscopic and immunohistochemical observation of hepatitis B virus-associated acquired bilateral telangiectatic macules in a Chinese man. An Bras Dermatol 2021; 96: 791-793.
https://doi.org/10.1016/j.abd.2020.08.027 DOI: https://doi.org/10.1016/j.abd.2020.08.027
Wang G, Chen H, Yang Y, Wu K, Sun J. Telangiectasia macularis multiplex acquisita accompanied by hepatitis B infection. Australas J Dermatol 2017; 58: e5-7.
https://doi.org/10.1111/ajd.12398 DOI: https://doi.org/10.1111/ajd.12398
Kim GW, Shin K, Kim TW, You HS, Jin HJ, Shim WH, et al. The importance of dermoscopy for the diagnosis of acquired bilateral telangiectatic macules: the angioid streak pattern reveals underlying chronic liver disease. J Eur Acad Dermatol Venereol 2018; 32: 1597-1601.
https://doi.org/10.1111/jdv.14669 DOI: https://doi.org/10.1111/jdv.14669
Jee H, Kim TG, Kim DS, Kim DY, Lee MG. Acquired bilateral nevoid telangiectasia: report of 9 cases. Eur J Dermatol 2013; 23: 736-737.
https://doi.org/10.1684/ejd.2013.2141 DOI: https://doi.org/10.1684/ejd.2013.2141
Reus WF, Robson MC, Zachary L, Heggers JP. Acute effects of tobacco smoking on blood flow in the cutaneous micro-circulation. Br J Plast Surg 1984; 37: 213-215.
https://doi.org/10.1016/0007-1226(84)90011-0 DOI: https://doi.org/10.1016/0007-1226(84)90011-0
Richardson D. Effects of tobacco smoke inhalation on capillary blood flow in human skin. Arch Environ Health 1987; 42: 19-25.
https://doi.org/10.1080/00039896.1987.9935790 DOI: https://doi.org/10.1080/00039896.1987.9935790
Francès C, Boisnic S, Hartmann DJ, Dautzenberg B, Branchet MC, Charpentier YL, et al. Changes in the elastic tissue of the non-sun-exposed skin of cigarette smokers. Br J Dermatol 1991; 125: 43-47.
https://doi.org/10.1111/j.1365-2133.1991.tb06037.x DOI: https://doi.org/10.1111/j.1365-2133.1991.tb06037.x
Kennedy C, Bastiaens MT, Bajdik CD, Willemze R, Westendorp RG, Bouwes Bavinck JN, et al. Leiden Skin Cancer Study: effect of smoking and sun on the aging skin. J Invest Dermatol 2003; 120: 548-584.
https://doi.org/10.1046/j.1523-1747.2003.12092.x DOI: https://doi.org/10.1046/j.1523-1747.2003.12092.x
Rocha JT, Hipólito UV, Callera GE, Yogi A, Neto Filho Mdos A, Bendhack LM, et al. Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways. Vascul Pharmacol 2012; 56: 74-83.
https://doi.org/10.1016/j.vph.2011.11.006 DOI: https://doi.org/10.1016/j.vph.2011.11.006
Ghosn SH, Kibbi AG. Cutaneous manifestations of liver diseases. Clin Dermatol 2008; 26: 274-282.
https://doi.org/10.1016/j.clindermatol.2008.02.001 DOI: https://doi.org/10.1016/j.clindermatol.2008.02.001
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol 1999; 94: 502-507. DOI: https://doi.org/10.1016/S0002-9270(98)00764-3
https://doi.org/10.1111/j.1572-0241.1999.883_l.x DOI: https://doi.org/10.1111/j.1572-0241.1999.883_l.x
Collins P, Ferguson J. Photodistributed nifedipine-induced facial telangiectasia. Br J Dermatol 1993; 129: 630-633.
https://doi.org/10.1111/j.1365-2133.1993.tb00501.x DOI: https://doi.org/10.1111/j.1365-2133.1993.tb00501.x
Tsele E, Chu AC. Nifedipine and telangiectasias. Lancet 1992; 339: 365-366.
https://doi.org/10.1016/0140-6736(92)91685-2 DOI: https://doi.org/10.1016/0140-6736(92)91685-2
Basarab T, Yu R, Jones RR. Calcium antagonist-induced photo-exposed telangiectasia. Br J Dermatol 1997; 136: 974-975.
https://doi.org/10.1111/j.1365-2133.1997.tb03952.x DOI: https://doi.org/10.1111/j.1365-2133.1997.tb03952.x
Grabczynska SA, Cowley N. Amlodipine induced-photosensitivity presenting as telangiectasia. Br J Dermatol 2000; 142: 1248-1256.
https://doi.org/10.1046/j.1365-2133.2000.03572.x DOI: https://doi.org/10.1046/j.1365-2133.2000.03572.x
Karonen T, Stubb S, Keski-Oja J. Truncal telangiectases coinciding with felodipine. Dermatology 1998; 196: 272-273.
Seggev JS, Lagstein Z. Photosensitivity skin reactions to calcium channel blockers. J Allergy Clin Immunol 1996; 97: 852-855.
https://doi.org/10.1016/S0091-6749(96)80164-3 DOI: https://doi.org/10.1016/S0091-6749(96)80164-3
Bakkour W, Haylett AK, Gibbs NK, Chalmers RJ, Rhodes LE. Photodistributed telangiectasia induced by calcium channel blockers: case report and review of the literature. Photodermatol Photoimmunol Photomed 2013; 29: 272-275.
https://doi.org/10.1111/phpp.12054 DOI: https://doi.org/10.1111/phpp.12054
Byun JW, Bang CI, Yang BH, Han SH, Song HJ, Lee HS, et al. Photodistributed telangiectasia induced by amlodipine. Ann Dermatol 2011; 23: S30-32.
https://doi.org/10.5021/ad.2011.23.S1.S30 DOI: https://doi.org/10.5021/ad.2011.23.S1.S30
Onoue S, Igarashi N, Yamada S, Tsuda Y. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances. J Pharm Biomed Anal 2008; 46: 187-193.
https://doi.org/10.1016/j.jpba.2007.09.003 DOI: https://doi.org/10.1016/j.jpba.2007.09.003
Khasnis A, Gokula RM. Spider nevus. J Postgrad Med 2002; 48: 307-309.
Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol 1997; 37: 523-549; quiz 549-552.
https://doi.org/10.1016/S0190-9622(97)70169-5 DOI: https://doi.org/10.1016/S0190-9622(97)70169-5
Katsamba AD, Karpouzis AJ, Koumantaki-Mathioudaki E, et al. Mastocytosis with skin manifestations: current status. J Eur Acad Dermatol Venereol 1999; 13: 148-165.
https://doi.org/10.1111/j.1468-3083.1999.tb00878.x DOI: https://doi.org/10.1111/j.1468-3083.1999.tb00878.x
Vano-Galvan S, Alvarez-Twose I, De las Heras E, Morgado JM, Matito A, Sánchez-Muñoz L, Jorizzo JL. Dermoscopic features of skin lesions in patients with mastocytosis. Arch Dermatol 2011; 147: 932-940.
https://doi.org/10.1001/archdermatol.2011.190 DOI: https://doi.org/10.1001/archdermatol.2011.190
Yang JY, Kim SM, Kim YC. Pulsed dye laser therapy in patients with acquired bilateral telangiectatic macules. Eur J Dermatol 2018; 28: 99-100.
https://doi.org/10.1684/ejd.2017.3159 DOI: https://doi.org/10.1684/ejd.2017.3159
Park JH, Lee DJ, Lee YJ, Jang YH, Kang HY, Kim YC. Acquired bilateral telangiectatic macules: a distinct clinical entity. JAMA Dermatol 2014; 150: 974-977.
https://doi.org/10.1001/jamadermatol.2013.10238 DOI: https://doi.org/10.1001/jamadermatol.2013.10238
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Tian Chen, Jia-Wei Liu, Yue-Tong Qian, Xing-Yu Li, Xiao Ma, Jing-Wen Wang, Dong-Lai Ma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.